MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-10-0010827
Bellissa Pharmaceuticals Private Limited - healthcare in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.03 Cr
▲ 27.75% YoY
Net profit · FY 2025
₹18.41 Lakh
Net margin 1.8%
EBITDA · FY 2025
₹83.98 Lakh
EBITDA margin 8.4%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹7.5 Lakh
Issued & subscribed
Open charges
₹80 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
70
Provident fund records
About Bellissa Pharmaceuticals Private Limited
Data last updated:
Bellissa Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 27 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33111WB2014PTC204431. Its GSTIN is 19AAGCB1085M1ZC (West Bengal). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹7.5 Lakh. It is led by directors Chacko Puthumana Mathai (Managing Director) and Magna Chacko.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17/43 N.S.C Bose Road 2/30 Ashoke Nagar, Kolkata, West Bengal, India – 700040.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.03 Cr. For the same year it recorded a net profit of ₹18.41 Lakh (net margin 1.8%) and EBITDA of ₹83.98 Lakh (EBITDA margin 8.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 6% over five years.
The company has about 70 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Bellissa. As per MCA filings, the company has open charges of ₹80 Lakh on record.
Bellissa Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0010827). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bellissapharma.com.
Company details
CIN U33111WB2014PTC204431
Registration Number 204431
Incorporation Date 27 November 2014
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-10-0010827
Recognitions & Rankings of Bellissa Pharmaceuticals
Contact details
Bellissa Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its website is bellissapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address17/43 N.S.C Bose Road 2/30 Ashoke Nagar, Kolkata, West Bengal, India – 700040
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Bellissa Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Bellissa Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bellissa Pharmaceuticals operates one associated brand: Bellissa. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company providing dermatology and cosmetology products with a focus on healthcare innovations. | bellissapharma.com |
Business activity
The main business activity of Bellissa Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Bellissa Pharmaceuticals Private Limited, buy the company report.
Financials of Bellissa Pharmaceuticals Private Limited
FY 2025 filings availableBellissa Pharmaceuticals Private Limited reported revenue of ₹10.03 Cr for FY 2025.
Revenue · FY 2025
₹10.03 Cr
Net profit · FY 2025
₹18.41 Lakh margin 1.8%
EBITDA · FY 2025
₹83.98 Lakh margin 8.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 13%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 28%
5 years · compounded
▲ 14%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹83.98 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.4% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bellissa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bellissa Pharmaceuticals Private Limited
Bellissa Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Magna Chacko | Director | 27 Nov 2014 | 11 Years 11 Months | Current |
| Chacko Puthumana Mathai | Managing Director | 27 Nov 2014 | 11 Years 11 Months | Current |
Auditor
Bellissa Pharmaceuticals Private Limited is audited by ASRM & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASRM & CO | FY 2023 | 328024E |
Shareholding
The shareholding of Bellissa Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bellissa Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹80 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Feb 2023 | 100697925 | Others | ₹80 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Bellissa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bellissa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bellissa Pharmaceuticals Private Limited has a workforce of 70 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
70
Active EPFO establishments
1
Employee growth
42.86%
GST
Bellissa Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAGCB1085M1ZC | West Bengal | Active | 01 Jul 2017 |
| 27AAGCB1085M1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Bellissa Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bellissa Pharmaceuticals Private Limited has 8 board changes on record since 2014: 2 appointments and 6 cessations. The latest: Amarjit Kumar Upadhyay ceased to be Director on 24 Feb 2015.
AGM
Bellissa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bellissa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Charges
A charge with Others amounted to Rs. 80.00 Lakh with Charge ID 100697925 was registered on 15 Feb 2023.
Ceased
Amarjit Kumar Upadhyay ceased to be Director.
Ceased
Anjan Kumar Karak ceased to be Director.
Ceased
Pulak Midya ceased to be Director.
Ceased
Saroj Kumar Padhi ceased to be Director.
Ceased
Arindam Koley ceased to be Director.
Ceased
Chacko Puthumana Mathai ceased to be Director.
Appointed
Chacko Puthumana Mathai was appointed as Managing Director.
Appointed
Magna Chacko was appointed as Director.
Incorporation
27 Nov 2014
Bellissa Pharmaceuticals Private Limited was registered on 27 Nov 2014 with Roc Kolkata & aged 11 years 11 months as per MCA records.
Frequently asked questions
Bellissa Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 27 November 2014 (12+ years old) and is registered under CIN U33111WB2014PTC204431.
Bellissa Pharmaceuticals has 2 current directors:
- Chacko Puthumana Mathai - Managing Director
- Magna Chacko - Director
The latest financial statements of Bellissa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bellissa Pharmaceuticals is 19AAGCB1085M1ZC, registered in West Bengal. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 27AAGCB1085M1ZF (Maharashtra).
The CIN (Corporate Identification Number) of Bellissa Pharmaceuticals is U33111WB2014PTC204431. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bellissa Pharmaceuticals was incorporated on 27 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
Amarjit Kumar Upadhyay ceased to be Director on 24 Feb 2015. Anjan Kumar Karak ceased to be Director on 24 Feb 2015. Pulak Midya ceased to be Director on 24 Feb 2015. Bellissa Pharmaceuticals has 8 board changes on record in total.
Yes, Bellissa Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0010827).
Bellissa Pharmaceuticals can be reached through the website bellissapharma.com. Its registered office is in Kolkata, West Bengal, India.
The registered office of Bellissa Pharmaceuticals is at 1743 N.S.C Bose Road 230 Ashoke Nagar, Kolkata, West Bengal, India – 700040.